[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
March 11, 1996

The Diagnosis and Treatment of Gastroesophageal Reflux Disease in a Managed Care EnvironmentSuggested Disease Management Guidelines

Author Affiliations

From the Departments of Medicine, Oregon Health Sciences University, Portland (Drs Fennerty and Lieberman), The Graduate Hospital, University of Pennsylvania, Philadelphia (Dr Castell), University of Michigan, Ann Arbor (Dr Fendrick), The Batelle Institute, Arlington, Va (Dr Halpern), Eastern Virginia School of Medicine, Norfolk (Dr Johnson), Northwestern University, Chicago, Ill (Dr Kahrilas), Cleveland Clinic Foundation, Cleveland, Ohio (Dr Richter), and Arizona Health Sciences Center, Tulsa (Dr Sampliner).

Arch Intern Med. 1996;156(5):477-484. doi:10.1001/archinte.1996.00440050019003

A group of experts from gastroenterology, internal medicine, health economics, medical outcomes, and managed care met in San Francisco, Calif, on September 27, 1994, in an effort to develop clinically and economically effective disease management guidelines to assist physicians in their treatment of gastroesophageal reflux disease in a managed care environment. This article represents a consensus opinion based on the evidence and expert interpretation at the time of that meeting.

(Arch Intern Med. 1996;156:477-484)